216
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Factors associated with development of retinopathy in patients with type 2 diabetes mellitus at onset and within three years after diagnosis

ORCID Icon, ORCID Icon & ORCID Icon
Received 10 Oct 2023, Accepted 06 Mar 2024, Published online: 22 Apr 2024

References

  • Kolb H, Martin S. Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes. BMC Med. 2017;1915(1):131. doi: 10.1186/s12916-017-0901-x.
  • Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diab Res Clin Pract. 2022;183:109119.
  • Swedish National Diabetes Register Annual Report. 2020. Gothenburg
  • Rawshani A, Rawshani A, Franzén S, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med. 2017;20;376(15):1407–1418. doi: 10.1056/NEJMoa1608664.
  • Khan RMM, Chua ZJY, Tan JC, et al. From pre-diabetes to diabetes: diagnosis, treatments and translation research. Medicina. 2019;55(9):546. 29doi: 10.3390/medicina55090546.
  • Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys Ther. 2008;88(11):1254–1264. doi: 10.2522/ptj.20080020.
  • European Society of Cardiology. 2019 Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD.
  • Wang W, Lo ACY. Diabetic retinopathy: pathophysiology and treatments. Int J Mol Sci. 2018;19(6):1816. doi: 10.3390/ijms19061816.
  • Yusufu M, Zhang X, Sun X, et al. How to perform better intervention to prevent and control diabetic retinopathy among patients with type 2 diabetes: a meta-analysis of randomized controlled trials. Diabetes Res Clin Pract. 2019;156:107834. doi: 10.1016/j.diabres.2019.107834.
  • Socialstyrelsen. Nationella riktlinjer för diabetesvård. Socialstyrelsen. 2018;
  • Li JQ, Welchowski T, Schmid M, et al. Prevalence, incidence and future projections of diabetic eye disease in Europe: a systematic review and meta-analysis. Eur J Epidemiol. 2020;35(1):11–23. doi: 10.1007/s10654-019-00560-z.
  • Ashfaq A, Lönn S, Nilsson H, et al. Data resource profile: regional healthcare information platform in Halland, Sweden. Int J Epidemiol. 2020;49(3):738–739f. doi: 10.1093/ije/dyz262.
  • Kidney Disease: improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Inter. Suppl. 2012;2:1–138.
  • Nyman U, Grubb A, Larsson A, et al. The revised Lund-Malmö estimating equation outperforms MDRD and CKD-EPI across GFR, age and BMI intervals in a large swedish population. Clin Chem Lab Med. 2014;52:815–824.
  • Ting DS, Cheung GC, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol. 2016;44(4):260–277. doi: 10.1111/ceo.12696.
  • Fong DS, Aiello L, Gardner TW, et al. American diabetes association; diabetic retinopathy. Diabetes Care. 2003;26(1):226–229. doi: 10.2337/diacare.26.1.226.
  • Yau JWY, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–564. doi: 10.2337/dc11-1909.
  • Shani M, Eviatar T, Komaneshter D, et al. Diabetic retinopathy – incidence and risk factors in a community setting – a longitudinal setting. Scand J Prim Health Care. 2018;36(3):237–241. doi: 10.1080/02813432.2018.1487524.
  • Teo ZL, Tham Y-C, Yu M, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology. 2021;128(11):1580–1591. doi: 10.1016/j.ophtha.2021.04.027.